GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,184,000 | +2.3% | 188,038 | +2.4% | 0.01% | +20.0% |
| Q1 2022 | $8,001,000 | -93.7% | 183,675 | -93.7% | 0.01% | -92.6% |
| Q4 2021 | $127,791,000 | +1598.7% | 2,897,717 | +1372.0% | 0.07% | +1600.0% |
| Q3 2021 | $7,523,000 | -63.2% | 196,859 | -61.6% | 0.00% | -66.7% |
| Q2 2021 | $20,434,000 | +31.8% | 513,197 | +18.1% | 0.01% | +20.0% |
| Q1 2021 | $15,506,000 | +13.4% | 434,480 | +16.9% | 0.01% | +25.0% |
| Q4 2020 | $13,678,000 | -12.3% | 371,695 | -10.3% | 0.01% | -20.0% |
| Q3 2020 | $15,589,000 | -44.5% | 414,157 | -39.9% | 0.01% | -54.5% |
| Q2 2020 | $28,089,000 | +35.6% | 688,613 | +26.0% | 0.02% | +15.8% |
| Q1 2020 | $20,710,000 | -24.4% | 546,563 | -6.3% | 0.02% | -5.0% |
| Q4 2019 | $27,397,000 | -5.5% | 583,088 | -14.1% | 0.02% | -13.0% |
| Q3 2019 | $28,983,000 | +4.3% | 679,060 | -2.2% | 0.02% | 0.0% |
| Q2 2019 | $27,799,000 | +21.7% | 694,586 | +27.0% | 0.02% | +4.5% |
| Q1 2019 | $22,848,000 | -35.6% | 546,734 | -41.1% | 0.02% | -37.1% |
| Q4 2018 | $35,489,000 | +67.4% | 928,755 | +76.0% | 0.04% | +84.2% |
| Q3 2018 | $21,195,000 | -38.7% | 527,604 | -38.5% | 0.02% | -40.6% |
| Q2 2018 | $34,592,000 | -29.8% | 858,135 | -31.9% | 0.03% | -22.0% |
| Q1 2018 | $49,302,000 | +71.5% | 1,261,004 | +55.6% | 0.04% | +78.3% |
| Q4 2017 | $28,751,000 | +37.2% | 810,588 | +57.1% | 0.02% | +35.3% |
| Q3 2017 | $20,951,000 | -14.3% | 516,045 | -9.0% | 0.02% | -26.1% |
| Q2 2017 | $24,458,000 | +11.6% | 567,209 | +9.1% | 0.02% | +15.0% |
| Q1 2017 | $21,920,000 | -65.4% | 519,928 | -68.4% | 0.02% | -64.9% |
| Q4 2016 | $63,268,000 | +152.0% | 1,642,915 | +182.2% | 0.06% | +147.8% |
| Q3 2016 | $25,109,000 | -4.2% | 582,176 | -3.7% | 0.02% | -14.8% |
| Q2 2016 | $26,204,000 | -20.8% | 604,631 | -25.9% | 0.03% | -27.0% |
| Q1 2016 | $33,084,000 | -49.9% | 815,891 | -50.2% | 0.04% | -43.9% |
| Q4 2015 | $66,056,000 | +82.2% | 1,637,078 | +73.6% | 0.07% | +94.1% |
| Q3 2015 | $36,256,000 | -38.8% | 942,933 | -33.7% | 0.03% | -34.6% |
| Q2 2015 | $59,213,000 | +70.5% | 1,421,667 | +88.9% | 0.05% | +52.9% |
| Q1 2015 | $34,735,000 | -42.4% | 752,671 | -46.7% | 0.03% | -37.0% |
| Q4 2014 | $60,321,000 | -3.2% | 1,411,372 | +4.1% | 0.05% | 0.0% |
| Q3 2014 | $62,296,000 | +33.0% | 1,355,149 | +54.8% | 0.05% | +22.7% |
| Q2 2014 | $46,828,000 | +51.2% | 875,606 | +51.1% | 0.04% | +41.9% |
| Q1 2014 | $30,961,000 | -12.8% | 579,495 | -12.9% | 0.03% | -6.1% |
| Q4 2013 | $35,526,000 | -27.8% | 665,408 | -32.1% | 0.03% | -28.3% |
| Q3 2013 | $49,181,000 | +59.9% | 980,267 | +59.2% | 0.05% | +53.3% |
| Q2 2013 | $30,765,000 | – | 615,646 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |